Zacks Investment Research downgraded shares of BRUKER CORP (BRKR) from OUTPERFORM to NEUTRAL on January 21, 2013, with a target price of $18.10.
As of February 26, 2008, the renamed BRUKER CORPORATION has become the parent company of the entire Bruker group of companies. After the closing of the acquisition of the Bruker BioSpin Group, Bruker Corporation now operates in two segments, the life science and analytical (LSA) systems segment, and the international advanced superconductor (IAS) segment.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on BRUKER CORP (BRKR),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment